Lexaria Bioscience Corp. (LEXX) Insider Trading Activity

NASDAQ$4.19+0.16 (3.97%)
Market Cap
$6.66M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
621 of 849
Rank in Industry
361 of 491

LEXX Insider Trading Activity

LEXX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoids and nicotine by 5 to 10 times, and in some cannabinoid applications, by as much as 27 times, when compared to standard formulations. DehydraTECH also …

Insider Activity of Lexaria Bioscience Corp.

Over the last 12 months, insiders at Lexaria Bioscience Corp. have bought $0 and sold $0 worth of Lexaria Bioscience Corp. stock.

On average, over the past 5 years, insiders at Lexaria Bioscience Corp. have bought $63,850 and sold $10,268 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 11,900 shares for transaction amount of $10,866 was made by BUNKA CHRISTOPHER (director) on 2025‑07‑30.

List of Insider Buy and Sell Transactions, Lexaria Bioscience Corp.

2025-07-30PurchaseBUNKA CHRISTOPHERdirector
11,900
0.0607%
$0.91
$10,866
-14.57%
2025-07-29PurchaseBUNKA CHRISTOPHERdirector
15,600
0.0827%
$0.92
$14,375
-12.07%
2025-07-29PurchaseCHRISTOPHER RICHARDChief Executive Officer
15,000
0.0784%
$0.91
$13,641
-12.07%
2025-07-29PurchaseMcKechnie William Edwarddirector
5,000
0.0261%
$0.91
$4,532
-12.07%
2025-07-29PurchaseDOCHERTY JOHN MARTINPresident & CSO
5,376
0.0287%
$0.93
$4,989
-12.07%
2025-07-29PurchaseCarle VanessaSecretary
750
0.0039%
$0.91
$683
-12.07%
2024-12-03PurchaseCHRISTOPHER RICHARDChief Executive Officer
27,172
0.1442%
$2.47
$67,175
-60.00%
2024-12-02PurchaseCHRISTOPHER RICHARDChief Executive Officer
22,828
0.1328%
$2.24
$51,217
-51.79%
2024-08-12PurchaseTURKEL CATHERINE C.director
1,600
0.0097%
$3.13
$5,008
-46.64%
2024-07-31SaleCarle VanessaSecretary
2,567
0.0177%
$4.00
$10,268
-55.87%
2023-02-09PurchaseTURKEL CATHERINE C.director
1,500
0.0253%
$2.84
$4,267
-55.28%
2022-10-14PurchaseDowney GregoryChief Financial Officer
121
0.002%
$2.09
$253
+1.66%
2022-10-13PurchaseBUNKA CHRISTOPHERChief Executive Officer
16,600
0.275%
$2.10
$34,860
+0.47%
2022-10-12PurchaseBUNKA CHRISTOPHERChief Executive Officer
21,900
0.3658%
$1.99
$43,537
+7.00%
2018-05-30SaleMcKechnie William Edward
47,900
0.0843%
$1.90
$91,011
Total: 15

Insider Historical Profitability

<0.0001%
BUNKA CHRISTOPHERdirector
281912
17.0598%
$1.14M40
<0.0001%
CHRISTOPHER RICHARDChief Executive Officer
65000
3.9334%
$261,950.0030
<0.0001%
McKechnie William Edwarddirector
18191
1.1008%
$73,309.7311
<0.0001%
DOCHERTY JOHN MARTINPresident & CSO
5376
0.3253%
$21,665.2810
<0.0001%
TURKEL CATHERINE C.director
3100
0.1876%
$12,493.0020
<0.0001%
Downey GregoryChief Financial Officer
1954
0.1182%
$7,874.6210
Carle VanessaSecretary
750
0.0454%
$3,022.5011
<0.0001%

Historical Insider Profitability vs. Competitors

$13,664,154
40
-70.35%
$7.05M
$29,645,465
28
8.09%
$6.48M
$63,749,694
24
-12.24%
$6.4M
$287,718
15
-41.45%
$5.68M
$1,246,170
12
65.67%
$5.42M

LEXX Institutional Investors: Active Positions

Increased Positions9+34.62%479,117+27.9%
Decreased Positions8-30.77%495,237-28.84%
New Positions2New203New
Sold Out Positions6Sold Out485,361Sold Out
Total Postitions27+3.85%2M-0.94%

LEXX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Invenomic Capital Management Lp$312.001.91%477,201-24,267-4.84%2025-09-30
Murchinson Ltd.$274.001.68%419,590+419,590New2025-09-30
Vanguard Group Inc$169.001.04%258,816+125,262+93.79%2025-09-30
Geode Capital Management, Llc$114.000.7%174,77900%2025-09-30
Toronto Dominion Bank$92.000.56%140,013+6,888+5.17%2025-09-30
State Street Corp$26.000.16%39,30100%2025-09-30
Wealth Enhancement Advisory Services, Llc$23.000.14%35,776+5,000+16.25%2025-09-30
Byrne Asset Management Llc$20.000.13%31,320-2,889-8.45%2025-09-30
Virtu Financial Llc$19.000.12%29,360+29,360New2025-09-30
Blackrock, Inc.$18.000.11%27,44500%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.